Korro Bio, Inc. (KRRO) Earnings Per Share (EPS)
Korro Bio, Inc. (KRRO) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2019-12-31 | N/A |
| 2020-12-31 | -$0.82 |
| 2021-12-31 | -$123.50 |
| 2022-12-31 | N/A |
| 2023-12-31 | -$53.08 |
| 2024-12-31 | -$9.37 |
| 2025-12-31 | -$12.48 |
How KRRO compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | -$5.83 |
| BHVN | Biohaven Ltd. | -$6.86 |
| AGIO | Agios Pharmaceuticals Inc. | -$7.12 |
| NKTR | Nektar Therapeutics | -$9.73 |
| QDEL | QuidelOrtho Corp Com | -$16.69 |
These are five companies in the same sector as KRRO with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Korro Bio, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("KRRO")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | KRRO | $13.49 | +1.81% | 0.08M |
| 3 | ||||
| 4 | ||||
| 5 |